In the present study, miR-532-3p was found to be down-regulated in PC and directly targeted DNMT3A, thereby participating in the progression of PC by regulating the expression of DNMT3A and SOCS2 in vitro and in vivo. This evidence concerns the gene SOCS2 and pachyonychia congenita.